Testing & evidence
Verified independent evidence
- Evidence status
- Verified independent evidence
- Manufacturer statement
- Supplied as a lyophilised powder across six vial sizes, every batch reaches ≥99{4126ccafc2fa8f847ceaeb6a91497cc67cd381373337e0df85dd9df95f3d94fa} purity confirmed by HPLC, with a Certificate of Analysis available on request. Independent lab paperwork for every research-peptide batch we currently hold in UK stock — each one confirming HPLC purity and mass-spectrometry identity, signed off by Janoshik Analytical.
- Laboratory
- Janoshik Analytical
- Certification body
- Not recorded
- Batch
- EGB-0126-RT20
- Batch-specific report
- Recorded
- Report date
- 2026-01-20
- Evidence checked
- 2026-09-20
- Purity (HPLC)
- 99.873%
- Chromatogram
- Not shown
- Identity / mass spectrometry
- Independent, identity stated
- Measured content
- Within 1% of label
- Lab verification
- Can be verified with the laboratory
- Microbiology / endotoxin
- Not shown
I found a product-specific Janoshik COA for Retatrutide 20mg matching the listed vial size and batch EGB-0126-RT20. The document shows HPLC purity and measured content, but no chromatogram image or additional contaminant, endotoxin, or sterility testing.